DirectorMoves ~ Harout Semerjian
Immunomedics (NASDAQ: IMMU) $4.67b Harout Semerjian $$$$ named CEO joins Board x- Ipsen Chief Commercial Officer
Base $675,000; Bonus 70%+ of base; Relocation bonus $225,000; Equity grant non-qualified SO 252,602 and 50,075 RSU